Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPulmonologynorthwood RAD E0470/E0471 Coverage Update | OpenPa…
    Ask Trek AI about this page
    CurrentnorthwoodPolicy N/A

    Respiratory Assist Device (RAD) coverage — E0470 / E0471

    Customize your policy alerts

    Sign up for all northwood policy alerts

    Know when northwood releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines coverage, medical necessity criteria, and documentation requirements for RADs (E0470, E0471) for Northwood members, including indications such as restrictive thoracic disorders, severe COPD, central or complex sleep apnea, hypoventilation syndromes, and chronic respiratory failure due to COPD. Affects treating practitioners, suppliers, and prior authorization processes.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    Payernorthwood
    PolicyRespiratory Assist Device (RAD) coverage — E0470 / E0471
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateJan 1, 2025
    Next Review DateDec 15, 2025
    Key ActionTreating practitioner must document symptoms and diagnostic data (e.g., ABG PaCO2, sleep oximetry/PSG, FVC or MIP) in the medical record to support device coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4 hrs/dayrequired average daily device use for continued coverage
    70%minimum percent of days device must be used (30-day)
    6 monthstypical initial coverage period for RAD (COPD)
    ≥52 mmHgPaCO2 threshold for severe COPD
    SpO2 ≤88% (≥5 min)nocturnal desaturation threshold
    61 daysminimum re-evaluation timing

    Coverage and Medical Necessity Criteria

    inv-01: Restrictive Thoracic Disorders — Covered when ALL of the following are met

    Covered when ALL of the following are met

    Restrictive Thoracic Disorders initial: A. Documentation in the medical record of a neuromuscular disease (e.g., ALS) or a severe thoracic cage abnormality (e.g., post-thoracoplasty); AND B. One of: (a) awake arterial blood gas PaCO2 ≥ 45 mm Hg while breathing the member's prescribed FiO2; (b) sleep oximetry shows SaO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum recording time 2 hours) while breathing the member's prescribed FiO2; (c) for neuromuscular disease only, either maximal inspiratory pressure < 60 cm H2O or forced vital capacity < 50% predicted; AND C. Chronic obstructive pulmonary disease does not contribute significantly to the member's pulmonary limitation.See node text

    If all criteria met, either E0470 or E0471 (practitioner judgment) is covered for the first three months of therapy.

    inv-02: Severe COPD (E0470) — Covered when ALL of the following are met

    Covered when ALL of the following are met

    Severe COPD initial (E0470): A. Awake arterial blood gas PaCO2 ≥ 52 mm Hg while breathing the member's prescribed FiO2; AND B. Sleep oximetry demonstrates SaO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum recording time 2 hours) while breathing oxygen at 2 LPM or the member's prescribed FiO2, whichever is higher; AND C. Prior to initiating therapy, sleep apnea and CPAP have been considered and ruled out (formal sleep testing not required if sufficient record exists).See node text

    If all criteria met, E0470 is covered for the first three months of therapy. If not met, E0470 and related accessories will be denied as not reasonable and necessary.

    inv-03: Escalation to E0471 for Severe COPD — An E0471 is covered for severe COPD members who qualified for E0470 when ONE of the following situations is met

    An E0471 is covered for severe COPD members who qualified for E0470 when ONE of the following situations is met

    Situation 1: A. Awake arterial blood gas PaCO2 while breathing the member's prescribed FiO2 worsens by ≥ 7 mm Hg compared to the original qualifying PaCO2; AND B. A facility-based PSG while using an E0470 device demonstrates SaO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum 2 hours) that is not caused by obstructive upper airway events (AHI < 5).See node text

    E0471 may be started any time after a period of initial E0470 use if both A and B are met.

    Situation 2: No sooner than 61 days after initial issue of the E0470 device: A. Awake arterial blood gas PaCO2 while breathing the member's prescribed FiO2 remains ≥ 52 mm Hg; AND B. Sleep oximetry while using the E0470 demonstrates SaO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum recording time 2 hours) while breathing oxygen at 2 LPM or the member's prescribed FiO2, whichever is higher.See node text

    If neither situation is met, billing for E0471 will be denied as not reasonable and necessary.

    inv-04: Central Sleep Apnea / Complex Sleep Apnea — Covered when ALL of the following are met prior to initiating therapy

    Covered when ALL of the following are met prior to initiating therapy

    CSA/CompSA initial: A. A complete facility-based, attended PSG documents the diagnosis of central sleep apnea (CSA) or complex sleep apnea (CompSA) per definitions (AHI ≥ 5 and CAHI ≥ 5 with central events >50%); AND B. The PSG documents significant improvement of sleep-associated hypoventilation with use of an E0470 or E0471 device on the settings to be prescribed for home while breathing the member's prescribed FiO2.AHI/CAHI criteria per definitions

    If criteria met, either E0470 or E0471 (practitioner judgment) will be covered for the first three months of therapy.

    inv-05: Situation 2: Severe COPD — upgrade to E0471 — Covered when ALL of the following are met for members with severe COPD who qualified for E0470 and being considered for E0471:

    Covered when ALL of the following are met for members with severe COPD who qualified for E0470 and being considered for E0471:

    Severe COPD to E0471 (Situation 2): A. At a time no sooner than 61 days after initial issue of E0470, awake arterial blood gas PaCO2 while breathing prescribed FiO2 remains ≥ 52 mm Hg; AND B. Sleep oximetry while using the E0470 device demonstrates SpO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum recording time 2 hours) while breathing oxygen at 2 LPM or prescribed FiO2, whichever is higher.PaCO2 ≥ 52 mm Hg; SpO2 ≤ 88% for ≥ 5 minutes (min 2 hours recording)

    Assessment must be performed no sooner than 61 days after initial E0470 issue; meeting both criteria supports coverage of E0471.

    inv-06: Central Sleep Apnea or Complex Sleep Apnea — Covered when ALL of the following are met for CSA or complex sleep apnea prior to initiating therapy:

    Covered when ALL of the following are met for CSA or complex sleep apnea prior to initiating therapy:

    CSA/CompSA initiation: A. Facility-based, attended PSG documents the diagnosis of CSA or CompSA; AND B. PSG documents significant improvement of sleep-associated hypoventilation with use of an E0470 or E0471 device on the settings to be prescribed for home while breathing the member's prescribed FiO2.Documented improvement on PSG

    If met, either E0470 or E0471 (practitioner judgment) covered for the first three months.

    inv-07: Hypoventilation Syndrome — E0470 — E0470 covered when ALL of A and B and EITHER C or D are met:

    E0470 covered when ALL of A and B and EITHER C or D are met:

    Hypoventilation E0470 A&B: A. Initial awake arterial blood gas PaCO2 while breathing prescribed FiO2 ≥ 45 mm Hg; AND B. Spirometry showing FEV1/FVC ≥ 70%.PaCO2 ≥ 45 mm Hg; FEV1/FVC ≥ 70%

    Refer to Chronic Respiratory Failure consequent to COPD for FEV1/FVC < 70%.

    Hypoventilation E0470 C or D: C. Awake arterial blood gas PaCO2 worsened by ≥ 7 mm Hg from the initial qualifying ABG OR D. A facility-based PSG or HST demonstrates SpO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum recording time 2 hours) that is not caused by obstructive events (AHI < 5).PaCO2 change ≥ 7 mm Hg OR SpO2 ≤ 88% ≥ 5 minutes (AHI <5)

    If neither C nor D is met, E0470 will be denied as not reasonable and necessary.

    inv-08: Hypoventilation Syndrome — E0471 — E0471 covered when ALL of A and B and EITHER C or D are met:

    E0471 covered when ALL of A and B and EITHER C or D are met:

    Hypoventilation E0471 A&B: A. A covered E0470 device is being used; AND B. Spirometry shows FEV1/FVC ≥ 70%.FEV1/FVC ≥ 70%

    Refer to severe COPD section for FEV1/FVC < 70%.

    Hypoventilation E0471 C or D: C. Awake arterial blood gas PaCO2 worsens by ≥ 7 mm Hg compared to the ABG used to qualify for E0470 OR D. A facility-based PSG or HST while using the E0470 demonstrates SpO2 ≤ 88% for ≥ 5 cumulative minutes of nocturnal recording time (minimum recording time 2 hours) that is not caused by obstructive events (AHI < 5).PaCO2 change ≥ 7 mm Hg OR SpO2 ≤ 88% ≥ 5 minutes (AHI <5)

    If criteria not met, E0471 will be denied as not reasonable and necessary.

    inv-09: RAD with Backup Rate Feature — Chronic Respiratory Failure (COPD) — RAD with backup rate feature covered for home use for an initial 6 months when ALL are met:

    RAD with backup rate feature covered for home use for an initial 6 months when ALL are met:

    RAD w/backup initial criteria: A. Awake PaCO2 ≥ 52 mm Hg by arterial blood gas while breathing the member's prescribed FiO2; AND B. Sleep apnea is not the predominant cause of hypercapnia (formal sleep testing not required if treating practitioner deems it not predominant); AND C. Member meets one of: (a) clinically stable COPD without increased/new respiratory symptoms for ≥ 2 days and no change in pharmacologic therapy in prior 2 weeks; OR (b) hypercapnia present ≥ 2 weeks post-hospitalization after resolution of COPD exacerbation requiring acute NIV.PaCO2 ≥ 52 mm Hg

    By the end of the initial 6-month period, therapy must meet high-intensity NIV settings (IPAP ≥ 15 cm H2O and backup rate ≥ 14 breaths/min).

    inv-10: RAD without Backup Rate Feature — COPD — RAD without backup rate covered for initial 6 months when ALL are met:

    RAD without backup rate covered for initial 6 months when ALL are met:

    RAD w/o backup initial criteria: A. Awake PaCO2 ≥ 52 mm Hg by arterial blood gas while breathing the member's prescribed FiO2; AND B. Sleep apnea is not the predominant cause of the hypercapnia (formal sleep testing not required if treating practitioner deems it not predominant).PaCO2 ≥ 52 mm Hg

    Intended for members who cannot tolerate high-intensity NIV or when backup rate is medically inappropriate; covered for initial 6 months.

    inv-11: RAD Upon Hospital Discharge — Covered when ALL are met for post-discharge RAD:

    Covered when ALL are met for post-discharge RAD:

    RAD on discharge: Member required a RAD or ventilator within 24 hours prior to hospital discharge; AND the treating practitioner determines the member is at risk of rapid symptom exacerbation or rise in PaCO2 after discharge.RAD/ventilator use within 24 hours prior to discharge

    If met, RAD with or without backup rate feature covered in the home immediately upon discharge for an initial 6-month period.

    inv-12: Continuing Usage and Outcome Criteria — Continued coverage after initial period requires specified usage and clinical outcomes:

    Continued coverage after initial period requires specified usage and clinical outcomes:

    First evaluation by 6 months: By the end of the initial 6-month period the treating practitioner must document that the member is using the RAD at least 4 hours per 24-hour period on at least 70% of days in a 30-day period AND has achieved at least one of: (A) normalization of PaCO2 to < 46 mm Hg; (B) stabilization of a rising PaCO2; (C) a 20% reduction in PaCO2 from baseline; OR (D) improvement in at least one hypercapnia-associated symptom (headache, fatigue, shortness of breath, confusion, or sleep quality).Device use ≥4 hrs/day on ≥70% of days in 30-day period; PaCO2 <46 mm Hg or 20% reduction or stabilization or symptom improvement

    Required for continued coverage beyond the initial period. A signed and dated practitioner statement completed no sooner than 61 days after initiation must attest to compliant use and benefit for continuation beyond three months.

    Second evaluation months 7-12: Between months 7-12 the treating practitioner must document ongoing use of at least 4 hours per 24-hour period on at least 70% of days in each paid rental month. After month 6, providers must document monthly that these usage thresholds are met for each remaining paid rental month and any month in which accessories/supplies are dispensed.Monthly documentation of 4 hrs/day on ≥70% days

    inv-13: Continued Coverage Requirement — Covered when policy criteria are met; otherwise coverage denied

    Covered when policy criteria are met; otherwise coverage denied

    RAD coverage requirement: Continued coverage of an E0470 or an E0471 device and related accessories requires meeting the policy criteria specified elsewhere in this document.

    If criteria are not met, continued coverage will be denied as not reasonable and necessary.

    inv-14: Coverage criteria revisions / cross-reference — Document notes revisions to initial coverage criteria and cross-references

    Document notes revisions to initial coverage criteria and cross-references

    coverage_revisions: Revisions recorded to the 'Initial Coverage Criteria for E0470 and E0471 devices' and to Hypoventilation Syndrome guidance; cross-reference to Chronic Respiratory Failure consequent to COPD for beneficiaries with FEV1/FVC < 70% is provided.

    This block documents revision statements and pointers to related sections; see full policy for complete revised language.

    If the coverage criteria for restrictive thoracic disorders are not fully met, then E0470 or E0471 and related accessories will be denied as not reasonable and necessary. This includes failure to document the required neuromuscular disorder or thoracic cage abnormality, the specified physiologic thresholds, or that COPD does not significantly contribute to the pulmonary limitation. See the continued coverage section for requirements beyond the initial three months.

    If the coverage criteria for severe COPD (E0470) are not fully met — including the arterial PaCO2 threshold, nocturnal desaturation requirements, or documentation that CPAP/sleep apnea have been considered — then E0470 and related accessories will be denied as not reasonable and necessary.

    No aspect of a home sleep test may be performed by a DME supplier. This prohibition explicitly includes delivery and/or pickup of the home sleep testing device by the supplier.

    Claims for A9279 (remote monitoring feature/device) are denied as non-covered; DME suppliers must not bill A9279 for remote monitoring services. Separately, the Exsufflation Belt (K1021) is considered experimental and investigational and is not covered for pulmonary restrictive or obstructive breathing.

    Claims for A9279 are denied as non-covered and suppliers must not bill A9279 for remote monitoring services. This denial is stated explicitly in the policy and reiterated in the change history.

    Billing for E0470 or E0471 will be considered not reasonable and necessary and denied when the specific coverage criteria for the indicated condition are not satisfied. Denials include failures to meet the stated physiologic thresholds, sleep testing or timing requirements, or the escalation criteria for E0471.

    If the clinical criteria and required timing for E0470, E0471 and related accessories are not met (including escalation timing, documented PaCO2 thresholds, nocturnal desaturation criteria, or required evaluations), the claim will be denied as not reasonable and necessary. Continued coverage beyond initial periods is contingent on meeting the policy's specified reassessment and usage requirements.

    Billing quantities of supplies greater than the policy-described usual maximum amounts will be denied as not reasonable and necessary. Suppliers should follow the policy table for per-code usual maximum amounts when dispensing accessories and replacement items.

    The Exsufflation Belt (K1021) is classified as experimental and investigational and is not covered for pulmonary restrictive or obstructive breathing. Claims for K1021 should be denied as not covered.

    HCPCS / Coding Tables

    Covered HCPCS Codes referencedHCPCSCovered
    E0470Noninvasive bi-level ventilator, without backup rate
    E0471Noninvasive bi-level ventilator, with backup rate
    E0601Continuous positive airway pressure (CPAP)
    Covered HCPCS Codes referenced (source descriptions)HCPCSCovered
    E0470RESPIRATORY ASSIST DEVICE, BI-LEVEL PRESSURE CAPABILITY, WITHOUT BACKUP RATE FEATURE, USED WITH NONINVASIVE INTERFACE
    E0471RESPIRATORY ASSIST DEVICE, BI-LEVEL PRESSURE CAPABILITY, WITH BACK-UP RATE FEATURE, USED WITH NONINVASIVE INTERFACE
    E0601Continuous positive airway pressure (CPAP)
    Covered HCPCS Codes (E0470/E0471)HCPCSCovered
    E0470Respiratory assist device, non-invasive ventilator, bi-level (without backup rate feature)
    E0471Respiratory assist device, non-invasive ventilator, bi-level (with backup rate feature)
    Primary RAD CodesHCPCSCovered
    E0470RESPIRATORY ASSIST DEVICE, BI-LEVEL PRESSURE CAPABILITY, WITHOUT BACKUP RATE FEATURE, USED WITH NONINVASIVE INTERFACE
    E0471RESPIRATORY ASSIST DEVICE, BI-LEVEL PRESSURE CAPABILITY, WITH BACK-UP RATE FEATURE, USED WITH NONINVASIVE INTERFACE
    Accessory and Related Device CodesHCPCSCovered
    A4604TUBING WITH INTEGRATED HEATING ELEMENT FOR USE WITH POSITIVE AIRWAY PRESSURE DEVICE
    A7027COMBINATION ORAL/NASAL MASK, USED WITH CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICE, EACH
    A7028N/A (listed among accessory codes)
    A7029NASAL PILLOWS FOR COMBINATION ORAL/NASAL MASK, REPLACEMENT ONLY, PAIR
    A7030FULL FACE MASK USED WITH POSITIVE AIRWAY PRESSURE DEVICE, EACH
    A7031FACE MASK INTERFACE, REPLACEMENT FOR FULL FACE MASK, EACH
    A7032N/A (listed among accessory codes)
    A7033N/A (listed among accessory codes)
    A7034N/A (listed among accessory codes)
    A7035HEADGEAR USED WITH POSITIVE AIRWAY PRESSURE DEVICE
    1–10 of 20
    1/2
    Noncovered HCPCS Codes (experimental/investigational)HCPCSNot Covered
    K1021EXSUFFLATION BELT, INCLUDES ALL SUPPLIES AND ACCESSORIES
    Denied / Not Covered CodesHCPCSNot Covered
    A9279MONITORING FEATURE/DEVICE, STAND-ALONE OR INTEGRATED, ANY TYPE, INCLUDES ALL ACCESSORIES, COMPONENTS AND ELECTRONICS, NOT OTHERWISE CLASSIFIED
    Policy-referenced HCPCS/CodesHCPCS
    E0467HCPCS code added to ventilator code listings
    A9279Remote monitoring services — claims denied as non-covered
    K1021Experimental and investigational
    A7027Accessory code (listed in historical changes)
    A7028Accessory code (listed in historical changes)
    A7029Accessory code (listed in historical changes)
    A7037Quantity changed to 1 per 3 months (historical)
    E0470Device code referenced in initial coverage criteria revisions
    E0471Device code referenced in initial coverage criteria revisions and prior least-cost alternative language
    Arterial PaCO2 thresholds by indication
    Restrictive thoracic disordersAwake arterial PaCO2 ≥45 mm Hg (done while breathing the member's prescribed FIO2)
    Severe COPD initial thresholdAwake arterial PaCO2 ≥52 mm Hg (done while breathing the member's prescribed FIO2)
    Hypoventilation (E0470) thresholdInitial awake PaCO2 ≥45 mm Hg for hypoventilation syndrome qualification
    Nocturnal oxygen saturation threshold and recording time
    Desaturation thresholdNocturnal SpO2 ≤88% for ≥5 cumulative minutes

    Provider Responsibilities, Prior Authorization, and Denial Risks

    Prior Authorization

    Prior authorization — follow Medicare/NCD guidance

    Refer to Medicare policy L33800 and NCD CAG-00465N for Medicare member coverage criteria; for non‑Medicare members, coverage is contingent on meeting the documented policy criteria prior to device coverage.

    Prior Authorization

    Initial 6‑month coverage period for RAD in COPD

    Initial home RAD coverage for COPD (with or without backup rate) is provided for an initial 6‑month period when the COPD-specific documentation and PaCO2 thresholds in the policy are met.

    Prior Authorization

    Coverage contingent on meeting policy criteria

    Coverage for E0470 and E0471 is conditional on meeting the policy's specific clinical criteria; failure to meet those criteria will result in denial of the device and related accessories.

    Background and Scope

    Respiratory assist devices (E0470, E0471) provide noninvasive bi-level ventilatory support for members with sleep-associated hypoventilation, neuromuscular respiratory weakness, severe COPD, central or complex sleep apnea, and related hypoventilation syndromes. Diagnostic evaluation to support coverage typically includes arterial blood gas measurement (PaCO2), sleep oximetry or attended polysomnography, and respiratory muscle testing (MIP or FVC) when neuromuscular disease is suspected. Coverage is conditional — devices are covered only when the policy's specific clinical criteria and documentation requirements are met, and continued coverage requires documented device usage and clinical improvement per the policy.

    Definitions and Terms

    Central sleep apnea (CSA) definition and thresholds
    CSA diagnostic criteriaAHI ≥5; central events >50% of total events; CAHI ≥5/hr; plus at least one symptom (e.g., sleepiness, insomnia, awakening short of breath, snoring, witnessed apneas)
    No hypoventilationThere must be no evidence of daytime or nocturnal hypoventilation for CSA diagnosis
    Testing requirementDiagnosis requires facility-based, attended PSG documenting CSA
    Complex sleep apnea (CompSA) definition
    CompSA identificationCentral apneas/hypopneas persist or emerge during use of positive airway pressure (E0601 or E0470) after obstructive events have been effectively treated (obstructive AHI <5)
    CAHI threshold on PAPAfter resolution of obstructive events, CAHI ≥5 per hour on PAP indicates CompSA

    Policy Revision History

    2006-11-20initial_release

    Initial policy release (first publication of the Respiratory Assist Device policy).

    2007-08-01quantity_update

    Added quantities to full face mask codes (accessory quantity updates).

    2008-03-13code_removal_and_definition_updates

    Removed E0472 and moved obstructive sleep apnea section to PAP policy; added definitions for K0554 and K0555 and other editorial changes.

    Policy Summary
    Payernorthwood
    PolicyRespiratory Assist Device (RAD) coverage — E0470 / E0471
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateJan 1, 2025
    Next Review DateDec 15, 2025
    Key ActionTreating practitioner must document symptoms and diagnostic data (e.g., ABG PaCO2, sleep oximetry/PSG, FVC or MIP) in the medical record to support device coverage.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaHCPCS / Coding TablesProvider Responsibilities, Prior Authorization, and Denial RisksBackground and ScopeDefinitions and TermsPolicy Revision History

    Failure to demonstrate compliant use is grounds for denial of continued coverage.

    Minimum recording timeMinimum total nocturnal recording time = 2 hours
    Testing contextRecording must be done while breathing the member's prescribed FIO2 or oxygen at 2 LPM where specified
    AHI / CAHI definitions and thresholds
    AHI diagnostic thresholdAHI ≥5 events per hour (without PAP)
    CAHI threshold for CSA/CompSACAHI ≥5 central events per hour
    Event definitionsApnea = cessation of airflow ≥10 seconds; Hypopnea = ≥10 seconds with ≥30% reduction in airflow and ≥4% desaturation
    Maximal inspiratory pressure / FVC thresholds for neuromuscular disease
    Maximal inspiratory pressure (MIP)MIP < 60 cm H2O (for neuromuscular disease)
    Forced vital capacity (FVC)FVC < 50% predicted (for neuromuscular disease)
    ContextThese criteria apply only for neuromuscular disease qualifying under restrictive thoracic disorder criteria
    PaCO2 thresholds summary across indications
    Severe COPD / RAD for COPDAwake PaCO2 ≥52 mm Hg (qualification and escalation thresholds)
    Hypoventilation initialAwake PaCO2 ≥45 mm Hg for hypoventilation syndrome qualification (E0470)
    PaCO2 worsening criterionIncrease in PaCO2 ≥7 mm Hg from baseline can justify escalation to E0471
    Device usage requirements for continued coverage (hours and percent days)
    Average daily use requiredAt least 4 hours per 24-hour period
    Minimum percent of daysUsed on ≥70% of days in a 30-day period
    Documentation cadenceAfter month 6, monthly documentation that thresholds are met for each paid rental month and any month supplies are dispensed
    High intensity NIV settings definition
    IPAP thresholdMinimum IPAP ≥15 cm H2O by end of initial 6-month period
    Backup respiratory rateBackup rate ≥14 breaths per minute by end of initial 6-month period
    Definition summaryHigh-intensity NIV = IPAP ≥15 cm H2O and backup rate ≥14 breaths/minute
    Usual Maximum Amounts (supply quantity limits) per code — varies by code
    A4604Usual maximum amount: 1 per 3 months
    A7037Usual maximum amount: 1 per 3 months (tubing)
    A7030 / A7031 (mask interfaces)Typical replacement frequencies vary (examples: 1 per 3 months to 2 per 1 month depending on code); see policy table
    inv-65: E0467 — home ventilator / multi-function device definition (coding context)
    E0467 descriptionHOME VENTILATOR, MULTI-FUNCTION RESPIRATORY DEVICE; integrates ventilator functions and may perform oxygen concentration, nebulization, aspiration, cough stimulation, PAP/RAD, and custom oral appliances
    Coding guidanceIf the multifunction device does not include all listed functions, it must not be coded as E0467
    Alternate codingMultifunction devices that combine some but not all listed functions must be coded as E1399
    Billing Rule

    New E0467 ventilator coding guidance

    HCPCS code E0467 was added to ventilator code listings and guidance for coding multifunction ventilators appears in the policy; ensure E0467 is used only when the device includes all listed multifunction features.

    • If the multifunction ventilator does not include all listed functions it must not be coded as E0467 (see policy).
    Step Therapy

    Step‑up from E0470 to E0471 requires documented escalation criteria

    For COPD members initially covered with E0470, escalation to E0471 is permitted only after documented worsening PaCO2 (≥7 mm Hg from baseline) with PSG confirmation OR per Situation 2 criteria evaluated no sooner than 61 days after initial E0470 issue showing persistent PaCO2 ≥52 mm Hg and nocturnal SpO2 ≤88% (≥5 cumulative minutes, min 2‑hour recording).

    • Situation 1: PaCO2 worsens ≥7 mm Hg vs original ABG AND facility PSG on E0470 shows SpO2 ≤88% ≥5 minutes (AHI <5).
    • Situation 2: No sooner than 61 days after E0470 issue, PaCO2 remains ≥52 mm Hg AND sleep oximetry on E0470 shows SpO2 ≤88% ≥5 minutes (min 2 hours recording).
    Prior Authorization

    Post‑discharge RAD — documentation and timing

    Post‑discharge RAD coverage is allowed immediately upon hospital discharge for an initial 6‑month period when the member required a RAD or ventilator within 24 hours prior to discharge and the treating practitioner documents the member is at risk of rapid symptom exacerbation or PaCO2 rise.

    Documentation Required

    Document diagnostic data and symptoms in medical record

    The treating practitioner must document symptoms characteristic of sleep‑associated hypoventilation and include specific diagnostic data (e.g., awake ABG PaCO2, sleep oximetry or PSG results, FVC or MIP for neuromuscular disease) in the medical record to support coverage.

    • Examples of required data: ABG PaCO2, sleep oximetry/PSG nocturnal SpO2 results, spirometry (FEV1/FVC), MIP or FVC for neuromuscular disease.
    Documentation Required

    Sleep study recording time — event count requirement

    If AHI or CAHI is calculated from less than 2 hours of continuous recorded sleep, the total number of recorded events used must be at least the number that would be required in a 2‑hour period (≥10 events) when computing indices.

    Documentation Required

    Practitioner attestation required for continued coverage

    For continued coverage beyond the initial period, obtain a signed and dated practitioner statement completed no sooner than 61 days after therapy initiation confirming the member is using the device an average of 4 hours per 24‑hour period and is benefiting from therapy.

    • Supplier must obtain this attestation for continued coverage beyond three months.
    Documentation Required

    ACA 6407 — face‑to‑face exam and documentation

    Per ACA 6407, the treating physician (practitioner) must conduct a face‑to‑face examination within six months prior to the written order and ensure the documentation describing the medical condition is received prior to delivery for applicable DME items.

    Billing Rule

    Do not bill A9279 for remote monitoring

    If a supplier bills A9279 for remote monitoring services, the claim will be denied as non‑covered; DME suppliers must not bill A9279 for remote monitoring.

    Denial Risk

    Denial risk — unmet coverage criteria

    E0470, E0471 and related accessories will be denied as not reasonable and necessary when the listed coverage criteria for the indicated clinical situation are not met.

    Denial Risk

    Denial risk — E0471 billed without required escalation evidence

    An E0471 billed without meeting the escalation criteria (Situation 1 or Situation 2) will be denied as not reasonable and necessary.

    Denial Risk

    Claim denial when device clinical criteria are not met

    If E0470 or E0471 is billed but the specific clinical criteria for the relevant indication (including thresholds and timing) are not met, the claim will be denied as not reasonable and necessary.

    Denial Risk

    Denial risk — continued coverage unmet

    If continuation criteria (usage, outcomes, reevaluation timelines) are not met, continued coverage of E0470/E0471 and accessories will be denied as not reasonable and necessary.

    Denial Risk

    Denial risk — excess supply quantities

    Billing quantities of supplies greater than the policy's usual maximum amounts will be denied as not reasonable and necessary; follow the accessory quantity limits in the policy table.

    Denial Risk

    Denial — A9279 is non‑covered

    Claims for A9279 are denied as non‑covered; do not submit A9279 for remote monitoring services.

    Denial Risk

    A9279 denied (policy restatement)

    Claims for A9279 are denied as non‑covered (policy reiteration).

    Central events proportionCentral events must comprise >50% of total apneas and hypopneas after obstruction resolution
    Apnea/Hypopnea/AHI/CAHI technical definitions
    Apnea definitionCessation of airflow ≥10 seconds
    Hypopnea definitionEvent ≥10 seconds with ≥30% reduction in airflow and ≥4% oxygen desaturation
    AHI / CAHIAHI = average apneas+hypopneas per sleep hour without PAP; CAHI = average central events per hour without PAP (or on PAP for CompSA)
    High intensity NIV definition
    Minimum therapy settings (high intensity NIV)IPAP ≥15 cm H2O and backup rate ≥14 breaths per minute by the end of the initial 6-month period
    ApplicationRequired by end of initial 6-month RAD with backup rate coverage for COPD
    PurposeDefines 'high intensity' required for continued coverage at reassessment
    Hypoventilation criteria (summary for E0470 qualification)
    E0470 hypoventilation criteria summaryAwake PaCO2 ≥45 mm Hg plus FEV1/FVC ≥70% AND either PaCO2 worsening ≥7 mm Hg or PSG/HST showing SpO2 ≤88% for ≥5 minutes (min 2 hours) with AHI <5
    E0471 hypoventilation criteria summaryRequires prior covered E0470 use, FEV1/FVC ≥70%, and either PaCO2 worsening ≥7 mm Hg from the qualifying ABG or PSG/HST while using E0470 showing SpO2 ≤88% ≥5 minutes (min 2 hours) with AHI <5
    Recording and AHI contextNocturnal desaturation criteria require minimum 2-hour recording and desaturations not due to obstructive events (AHI <5)
    inv-65: E0467 — home ventilator definition
    E0467 definitionHome ventilator, multi-function respiratory device that integrates ventilator functions and may include oxygen concentration, nebulization, aspiration, cough stimulation, PAP/RAD, and custom oral appliances
    Coding conditionIf the multifunction ventilator does not include all listed functions it must not be coded as E0467; partial-function devices should be coded as E1399
    Policy noteE0467 is not appropriate for treatment of OSA per policy guidance (refer to Ventilator Policy)
    2009-12-15accessory_codes_and_quantity_change

    Added accessory codes A7027–A7029 and changed quantity of A7037 to 1 per 3 months; policy updated/annual review entries recorded.

    2010-12-03annual_review

    Annual review completed with no material changes documented.

    2011-07-20note_added

    Added Important Note to all Medical Policies.

    2011-11-10annual_review

    Annual review; references to policy added.

    2012-04-04reference_added

    Added reference to NH Medicaid.

    2012-12-03annual_review

    Annual review completed with no changes.

    2013-12-11annual_review

    Annual review completed with no changes.

    2014-12-04annual_review

    Annual review completed.

    2018-12-10annual_review_and_guideline_addition

    Annual review performed; added E0467 coding guidelines to ventilator code listings.

    2019-12-05annual_review

    Annual review completed; no clinical changes noted (recorded as annual review with added E0467 guidance carried forward).

    2020-12-10terminology_update

    Annual review; revised terminology from 'physician' to 'practitioner'.

    2021-12-15coding_and_policy_updates

    Annual review; added HCPCS code E0467 to ventilator listings, prohibited DME suppliers from performing any aspect of a home sleep test, and recorded that claims for A9279 are denied as non-covered.

    2022-09-15annual_review_and_noncovered_update

    Annual review; K1021 classified as experimental and investigational and added to policy references.

    2022-12-15annual_review

    Annual review completed (no further changes beyond prior updates).

    2023-12-05annual_review

    Annual review completed with no changes recorded.

    2024-12-09annual_review

    Annual review completed with no changes recorded.

    2025-07-17ncd_addition

    Annual review recorded adding new NCD coverage criteria for Chronic Respiratory Failure consequent to COPD.

    2025-12-15annual_review_and_criteria_revisionLatest

    Annual review scheduled/recorded; revised 'Initial Coverage Criteria for E0470 and E0471' and other coverage criteria cross-references for 2025 updates.